ACAD SHAREHOLDER DEADLINE TOMORROW: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now
June 17, 2021 09:36 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 17, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
ACAD 6-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, Deadline Approaching in Securities Class Action
June 12, 2021 11:16 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
ACAD 11-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Before the June 18th Deadline in Securities Fraud Lawsuit
June 07, 2021 15:04 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 07, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, June 18th Deadline Approaching in Securities Fraud Lawsuit
June 02, 2021 17:17 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 02, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, June 18th Deadline Approaching in Securities Fraud Lawsuit
May 28, 2021 09:35 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Acadia Pharmaceuticals (ACAD) Investors of Securities Fraud Lawsuit, Investors with Losses Secure Counsel
May 23, 2021 11:21 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, Securities Fraud Class Action Filed
May 18, 2021 11:53 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Acadia Pharmaceuticals (ACAD) Investors to Securities Class Action, Advises Investors with Losses to Contact Its Attorneys Now
May 08, 2021 11:10 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 08, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Pending, Deadline Approaching
April 26, 2021 14:42 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Filed
April 20, 2021 15:45 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 20, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...